Design, synthesis, and evaluation of novel benzoylhydrazone derivatives as Nur77 modulators with potent antitumor activity against hepatocellular carcinoma

Nur77 modulators have emerged as a promising therapeutic approach for hepatocellular carcinoma. In this study, a structure-based rational drug design approach was used to design and synthesise a series of 4-((8-hydroxy-2-methylquinolin-4-yl)amino)benzoylhydrazone derivatives based on the binding cha...

Full description

Bibliographic Details
Main Authors: Fengming He, Jun Chen, Taige Zhao, Qiaoqiong Wu, Na Yin, Xiumei Wang, Yijing Zhong, Xiaodan Guo, YingKun Qiu, Baicun Li, Meijuan Fang, Zhen Wu
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Journal of Enzyme Inhibition and Medicinal Chemistry
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/14756366.2023.2227777
_version_ 1827123363553738752
author Fengming He
Jun Chen
Taige Zhao
Qiaoqiong Wu
Na Yin
Xiumei Wang
Yijing Zhong
Xiaodan Guo
YingKun Qiu
Baicun Li
Meijuan Fang
Zhen Wu
author_facet Fengming He
Jun Chen
Taige Zhao
Qiaoqiong Wu
Na Yin
Xiumei Wang
Yijing Zhong
Xiaodan Guo
YingKun Qiu
Baicun Li
Meijuan Fang
Zhen Wu
author_sort Fengming He
collection DOAJ
description Nur77 modulators have emerged as a promising therapeutic approach for hepatocellular carcinoma. In this study, a structure-based rational drug design approach was used to design and synthesise a series of 4-((8-hydroxy-2-methylquinolin-4-yl)amino)benzoylhydrazone derivatives based on the binding characteristics of our previously reported 10g and the native ligand 3NB at the binding Site C of Nur77. Cell-based cytotoxicity assays revealed that compound TMHA37 demonstrated the highest cytotoxicity against all tested cancer cells. The induced fit docking and binding pose metadynamics simulation suggested that TMHA37 was the most promising Nur77 binder at Site C. Molecular dynamics simulation validated the stable binding of TMHA37 to Nur77’s Site C but not to Sites A or B. Specifically, TMHA37 bound strongly to Nur77-LBD (KD = 445.3 nM) and could activate Nur77’s transcriptional activity. Furthermore, TMHA37 exhibited antitumor effects by blocking the cell cycle at G2/M phase and inducing cell apoptosis in a Nur77-dependent manner.
first_indexed 2024-03-09T02:03:05Z
format Article
id doaj.art-ad13e54480a744138d8c675f5f6cad66
institution Directory Open Access Journal
issn 1475-6366
1475-6374
language English
last_indexed 2025-03-20T14:23:44Z
publishDate 2023-12-01
publisher Taylor & Francis Group
record_format Article
series Journal of Enzyme Inhibition and Medicinal Chemistry
spelling doaj.art-ad13e54480a744138d8c675f5f6cad662024-09-09T17:23:18ZengTaylor & Francis GroupJournal of Enzyme Inhibition and Medicinal Chemistry1475-63661475-63742023-12-0138110.1080/14756366.2023.2227777Design, synthesis, and evaluation of novel benzoylhydrazone derivatives as Nur77 modulators with potent antitumor activity against hepatocellular carcinomaFengming He0Jun Chen1Taige Zhao2Qiaoqiong Wu3Na Yin4Xiumei Wang5Yijing Zhong6Xiaodan Guo7YingKun Qiu8Baicun Li9Meijuan Fang10Zhen Wu11School of Pharmaceutical Sciences, Xiamen University, Xiamen, P.R. ChinaSchool of Pharmaceutical Sciences, Xiamen University, Xiamen, P.R. ChinaSchool of Pharmaceutical Sciences, Xiamen University, Xiamen, P.R. ChinaSchool of Pharmaceutical Sciences, Xiamen University, Xiamen, P.R. ChinaSchool of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, P.R. ChinaSchool of Pharmaceutical Sciences, Xiamen University, Xiamen, P.R. ChinaSchool of Pharmaceutical Sciences, Xiamen University, Xiamen, P.R. ChinaSchool of Pharmaceutical Sciences, Xiamen University, Xiamen, P.R. ChinaSchool of Pharmaceutical Sciences, Xiamen University, Xiamen, P.R. ChinaCenter of Respiratory Medicine, China-Japan Friendship Hospital, National Center for Respiratory Medicine, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, National Clinical Research Center for Respiratory Diseases, Beijing, P.R. ChinaSchool of Pharmaceutical Sciences, Xiamen University, Xiamen, P.R. ChinaSchool of Pharmaceutical Sciences, Xiamen University, Xiamen, P.R. ChinaNur77 modulators have emerged as a promising therapeutic approach for hepatocellular carcinoma. In this study, a structure-based rational drug design approach was used to design and synthesise a series of 4-((8-hydroxy-2-methylquinolin-4-yl)amino)benzoylhydrazone derivatives based on the binding characteristics of our previously reported 10g and the native ligand 3NB at the binding Site C of Nur77. Cell-based cytotoxicity assays revealed that compound TMHA37 demonstrated the highest cytotoxicity against all tested cancer cells. The induced fit docking and binding pose metadynamics simulation suggested that TMHA37 was the most promising Nur77 binder at Site C. Molecular dynamics simulation validated the stable binding of TMHA37 to Nur77’s Site C but not to Sites A or B. Specifically, TMHA37 bound strongly to Nur77-LBD (KD = 445.3 nM) and could activate Nur77’s transcriptional activity. Furthermore, TMHA37 exhibited antitumor effects by blocking the cell cycle at G2/M phase and inducing cell apoptosis in a Nur77-dependent manner.https://www.tandfonline.com/doi/10.1080/14756366.2023.2227777Nur77Benzoylhydrazone derivativeshepatocellular carcinomamolecular dynamics simulationantitumor activity
spellingShingle Fengming He
Jun Chen
Taige Zhao
Qiaoqiong Wu
Na Yin
Xiumei Wang
Yijing Zhong
Xiaodan Guo
YingKun Qiu
Baicun Li
Meijuan Fang
Zhen Wu
Design, synthesis, and evaluation of novel benzoylhydrazone derivatives as Nur77 modulators with potent antitumor activity against hepatocellular carcinoma
Journal of Enzyme Inhibition and Medicinal Chemistry
Nur77
Benzoylhydrazone derivatives
hepatocellular carcinoma
molecular dynamics simulation
antitumor activity
title Design, synthesis, and evaluation of novel benzoylhydrazone derivatives as Nur77 modulators with potent antitumor activity against hepatocellular carcinoma
title_full Design, synthesis, and evaluation of novel benzoylhydrazone derivatives as Nur77 modulators with potent antitumor activity against hepatocellular carcinoma
title_fullStr Design, synthesis, and evaluation of novel benzoylhydrazone derivatives as Nur77 modulators with potent antitumor activity against hepatocellular carcinoma
title_full_unstemmed Design, synthesis, and evaluation of novel benzoylhydrazone derivatives as Nur77 modulators with potent antitumor activity against hepatocellular carcinoma
title_short Design, synthesis, and evaluation of novel benzoylhydrazone derivatives as Nur77 modulators with potent antitumor activity against hepatocellular carcinoma
title_sort design synthesis and evaluation of novel benzoylhydrazone derivatives as nur77 modulators with potent antitumor activity against hepatocellular carcinoma
topic Nur77
Benzoylhydrazone derivatives
hepatocellular carcinoma
molecular dynamics simulation
antitumor activity
url https://www.tandfonline.com/doi/10.1080/14756366.2023.2227777
work_keys_str_mv AT fengminghe designsynthesisandevaluationofnovelbenzoylhydrazonederivativesasnur77modulatorswithpotentantitumoractivityagainsthepatocellularcarcinoma
AT junchen designsynthesisandevaluationofnovelbenzoylhydrazonederivativesasnur77modulatorswithpotentantitumoractivityagainsthepatocellularcarcinoma
AT taigezhao designsynthesisandevaluationofnovelbenzoylhydrazonederivativesasnur77modulatorswithpotentantitumoractivityagainsthepatocellularcarcinoma
AT qiaoqiongwu designsynthesisandevaluationofnovelbenzoylhydrazonederivativesasnur77modulatorswithpotentantitumoractivityagainsthepatocellularcarcinoma
AT nayin designsynthesisandevaluationofnovelbenzoylhydrazonederivativesasnur77modulatorswithpotentantitumoractivityagainsthepatocellularcarcinoma
AT xiumeiwang designsynthesisandevaluationofnovelbenzoylhydrazonederivativesasnur77modulatorswithpotentantitumoractivityagainsthepatocellularcarcinoma
AT yijingzhong designsynthesisandevaluationofnovelbenzoylhydrazonederivativesasnur77modulatorswithpotentantitumoractivityagainsthepatocellularcarcinoma
AT xiaodanguo designsynthesisandevaluationofnovelbenzoylhydrazonederivativesasnur77modulatorswithpotentantitumoractivityagainsthepatocellularcarcinoma
AT yingkunqiu designsynthesisandevaluationofnovelbenzoylhydrazonederivativesasnur77modulatorswithpotentantitumoractivityagainsthepatocellularcarcinoma
AT baicunli designsynthesisandevaluationofnovelbenzoylhydrazonederivativesasnur77modulatorswithpotentantitumoractivityagainsthepatocellularcarcinoma
AT meijuanfang designsynthesisandevaluationofnovelbenzoylhydrazonederivativesasnur77modulatorswithpotentantitumoractivityagainsthepatocellularcarcinoma
AT zhenwu designsynthesisandevaluationofnovelbenzoylhydrazonederivativesasnur77modulatorswithpotentantitumoractivityagainsthepatocellularcarcinoma